Apapa Customs records over N1.8trn revenue in 10mths
•Outpaces 2023 collection by 101%
•Confiscates 6 containers of expired pharmaceuticals
The Apapa Area One Command of the Nigeria Customs Service (NCS) has announced that it has collected over N1.8 trillion in revenue for the first ten months of 2024, marking a 101% increase compared to the N931 billion collected during the same period in 2023.
The performance includes the highest monthly collection in the command’s history, with N264.4 billion generated in October.
Speaking to reporters in Lagos, the Command’s Area Comptroller, Dr. Babatunde Olomu, expressed optimism that the command is on track to exceed its 2024 revenue target of N2.2 trillion.
Furthermore, the command seized six containers of expired pharmaceutical products, which have been handed over to the National Drug Law Enforcement Agency (NDLEA).
Olumu said, “Despite a noticeable decline in trade volume, this command has blocked revenue leakages and maximized collection,” Olomu noted. “From January to October 2024, we generated a total of N1.875 trillion, surpassing last year’s figure by 101%.”
Highlighting the command’s commitment to efficiency, Olomu added that the Apapa Command has embraced trade facilitation tools such as the Authorised Economic Operator (AEO) program and Advanced Ruling. Additionally, the command operates on weekends to expedite cargo delivery, aligning with the Federal Government’s Ease of Doing Business initiative.
The command recently facilitated the first shipment of cargo to Kenya under the African Continental Free Trade Area (AfCFTA) regime, reflecting its role in promoting intra-African trade.
Apapa Customs records over N1.8trn revenue in 10 months, surpasses 2023 collection by 101%
Oyo/Osun Customs recovers over N56bn amidst smuggling crackdown
Olomu stated the robust collaboration with sister agencies, as six containers of unwholesome and falsely declared pharmaceutical products are to be transferred to the National Agency for Food and Drug Administration and Control (NAFDAC) and the NDLEA. These items, including unapproved dosages of tramadol and codeine-laced cough syrups, pose health risks and violate Nigeria’s Common External Tariff (CET) Schedule 3 and Section 233 of the NCS Act 2023.